2. Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update 2016;22:116-133.
6. Bar-Lavan Y, Shemesh N, Ben-Zvi A. Chaperone families and interactions in metazoa. Essays Biochem 2016;60:237-253.
9. Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. Heat shock proteins and cancer. Trends Pharmacol Sci 2017;38:226-256.
10. Toursel C, Dzierszinski F, Bernigaud A, Mortuaire M, Tomavo S. Molecular cloning, organellar targeting and developmental expression of mitochondrial chaperone HSP60 in
Toxoplasma gondii
. Mol Biochem Parasitol 2000;111:319-332.
11. Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F.
Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen. Exp Parasitol 2009;122:41-46.
12. Wang F, Liu F, Liu H, Chen W, Si X, Ma X. Effects of immunological and hematological parameter in mice exposed to mixture of volatile organic compounds. Inhal Toxicol 2016;28:164-169.
13. Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, Zhu XQ. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic
Toxoplasma gondii infection in mice. Vaccine 2014;32:3058-3065.
14. Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, Zhu XQ. Protective efficacy of two novel DNA vaccines expressing
Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines 2015;14:1289-1297.
15. Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, Zhou Y, Yang GL, Zhu XQ. Evaluation of protective effect of pVAX-Tg-MIC13 plasmid against acute and chronic
Toxoplasma gondii infection in a murine model. Vaccine 2013;31:3135-3139.
16. Ota Y, Ishihara S, Otani K, Yasuda K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T. Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes. Mol Clin Oncol 2016;4:607-610.
17. Kur J, Holec-Gasior L, Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 2009;8:791-808.
19. Yarovinsky F. Innate immunity to
Toxoplasma gondii infection. Nat Rev Immunol 2014;14:109-121.
20. Burrells A, Benavides J, Cantón G, Garcia JL, Bartley PM, Nath M, Thomson J, Chianini F, Innes EA, Katzer F. Vaccination of pigs with the S48 strain of
Toxoplasma gondii--safer meat for human consumption. Vet Res 2015;46:47.
22. Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016;15:313-329.
23. Han Y, Zhou A, Lu G, Zhao G, Sha W, Wang L, Guo J, Zhou J, Zhou H, Cong H, He S. DNA vaccines encoding
Toxoplasma gondii cathepsin C1 induce protection against toxoplasmosis in mice. Korean J Parasitol 2017;55:505-512.
24. Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. DNA immunization with eukaryotic initiation factor-2α of
Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013;31:6225-6231.
25. Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ. Evaluation of immuno-efficacy of a novel DNA vaccine encoding
Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis 2014;14:525.
27. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with
Toxoplasma gondii
. J Immunol 1994;153:2533-2543.
28. Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and
Toxoplasma gondii
. Schizophr Bull 2009;35:1163-1182.
29. Davidson MG. Toxoplasmosis. Vet Clin North Am Small Anim Pract 2000;30:1051-1062.